NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 712578 | Null | 0.00770426557728501 | 0.32195513 |
NSC 715559 | Null | 0.00770426557728501 | 0.33632129 |
NSC 733752 | Null | 0.00770426557728501 | 0.39290406 |
NSC 734307 | 3,4-Dihydroxy-N(3-O-methyl-estra-1,3,5(10)-trien-ol-17b-yl)c innamide | 0.00770426557728506 | 0.20926767 |
NSC 73735 | B 3845 | 0.00770426557728506 | 0.33821761 |
NSC 743434 | 8-(4-{5-[3-(4-fluoro phenyl)-3-oxo-1-prophenyl]-2-methoxy phenoxy}pentoxy)-7-methoxy-2,3,5,11-a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a],[1,4]diazepin-5-one | 0.00770426557728506 | 0.26636557 |
NSC 746928 | Null | 0.00770426557728506 | 0.28226303 |
NSC 752464 | methyl 2-((S,3Z)-6-((E)-1-hydroxy-3-phenylallylidene)-5-oxocyclohex-3-enyl)acetate | 0.00770426557728506 | 0.43456079 |
NSC 113497 | 16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) | 0.00803384002766641 | 0.3043196 |
NSC 114346 | Null | 0.00803384002766641 | 0.45106208 |